Training and Resources
GARDASIL® 9 (Human Papillomavirus 9-valent Vaccine) (Recombinant, adsorbed)
GARDASIL® 9 is indicated for active immunisation of individuals from the age of 9 years against the following HPV diseases: Premalignant lesions and cancers affecting the cervix, vulva, vagina and anus caused by vaccine HPV types; Genital warts (Condyloma acuminata) caused by specific HPV types.
Prescribing Information (Great Britain) & Prescribing Information (Northern Ireland)
By clicking the links above you will leave the MSD Connect website and be taken to the emc PI portal website
We are updating this page with new content to support the 2024-25 school programme
Please visit in August 2024 for new resources
Supporting documentation
GARDASIL® 9 (Human Papillomavirus 9-valent Vaccine) (Recombinant, adsorbed)
Prescribing Information (Great Britain) & Prescribing Information (Northern Ireland) [External links]
By clicking the links above you will leave the MSD Connect website and be taken to the emc PI portal website